• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Eisai Launches First Amazon Alexa Skill to Bring Solace & Support to Children with Epilepsy

by Fred Pennic 11/12/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Eisai Launches First Amazon Alexa Skill to Bring Solace & Support to Children with Epilepsy

 

– Eisai Inc. launches Ella the Jellyfish, the first Amazon Alexa skill designed for those affected by Lennox-Gastaut Syndrome (LGS), a rare and severe form of childhood-onset epilepsy.

– LGS can be characterized by frequent and unpredictable seizures, limited speech and mobility, cognitive impairment, and developmental delays.

– Available free of charge, , this unbranded Alexa skill provides comfort to children, families and caregivers through song, storytelling, meditation, and interactive games.

Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., today announced the launch of Ella the Jellyfish, the first Amazon Alexa skill designed for those affected by Lennox-Gastaut Syndrome (LGS). Available free of charge, the Alexa skill was created with input from children living with LGS, a rare and severe form of childhood-onset epilepsy, their families and caregivers.

Impact of LSG on Children 

 

When a child has a debilitating disease, everyday life for them, their families and caregivers can be challenging. LGS can be characterized by frequent and unpredictable seizures, limited speech and mobility, cognitive impairment, and developmental delays. Approximately 70 percent of patients with LGS will show cognitive impairment at diagnosis and more than 50 percent suffer behavioral issues including hyperactivity, sleep disturbances, aggression, and autistic symptoms.

As a result, some children with LGS feel isolated, even from their own family members. Given the need to provide 24-hour-a-day, seven-day-a-week support, families, and caregivers also often feel isolated, exhausted and overwhelmed.

A growing and influential trend transforming healthcare and pharma is the promise and power of voice-enabled technologies such as Amazon Alexa – it often doesn’t provide a way for those in need to receive solace and support – until now. Designed in collaboration with the LGS community, this unbranded Alexa skill provides comfort to children, families and caregivers through song, storytelling, meditation, and interactive games. Available free of charge, it can be downloaded and easily activated on Alexa-enabled devices, including voice assistants, mobile phones and tablets.

Ella the Jellyfish: How It Works

Featuring capabilities such as interactive play, listening, and creative activities, Ella the Jellyfish was designed for easy and seamless daily use on Alexa-enabled devices, including voice assistants, mobile phones and tablets. By simply saying, “Alexa, open Ella the Jellyfish,” families, caregivers and children can instantly and easily interact with Ella and her underwater friends by listening to Ella tell a story, singing a song, listening to a relaxing meditation or playing such games as “Ella Says, Freeze Dance” and “Color Hunt.”

Parents and guardians can enable Ella the Jellyfish skill by searching for Ella the Jellyfish in the Alexa Skills Store online and through the Alexa app. Once enabled, caregivers and patients can start by telling their Alexa-enabled device to open Ella the Jellyfish. Caregivers and patients can also learn how to operate the skill by watching videos of caregivers and children using Ella the Jellyfish. Those videos can be found at ellathejellyfish.com. 

“Ella the Jellyfish was born out of the countless, heartfelt experiences Eisai employees have had with the LGS community,” said Alexander Scott, Chief Strategy Officer, Neurology Business Group, Eisai Inc. “Staying true to our human health care mission to advance epilepsy care and help address the specific needs of patients and their families is what inspired us to develop Ella. Our goal is to relentlessly break through ordinary approaches so that we may provide innovative solutions that go beyond just the medicine.”

 Impact of Leveraging Voice-Enabled Technology to Address LSG

“When I treat children with LGS, I am always looking for ways to better help support caregivers and families navigate the daily challenges of taking care of someone with this disease,” said Michael Chez, MD, Pediatric Epileptologist, Sutter Medical Group, Sacramento, CA.  “Ella is a wonderful example of how technology can provide a new level of support and compassion.”

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Amazon, Amazon Alexa, assistants, Caregivers, Epilepsy, MD, medical group, Pharma, seizures

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Olive Secures $400M At A $4B Valuation to Support New Instant Claim Payment Solution

Olive Shutters Business After Sale to Waystar and Humata Health

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

FDA Grants Clearance for UltraSight's AI Cardiac Ultrasound

Israel Defense Forces to Utilize UltraSight’s PoCUS Devices in Combat

The Future of Biomarker-Based Therapy for Mental Disorder Care

The Future of Biomarker-Based Therapy for Mental Disorder Care

HLTH23: 6 Digital Health Executives Share Key Takeaways

6 Digital Health Executives Share Key Takeaways from HLTH23

HIMSS Appoints New Chief Financial Officer & General Counsel

HIMSS Appoints New Chief Financial Officer & General Counsel

GoodRx Now Offers Access to $35 Insulin to All Americans

GoodRx Now Offers Access to $35 Insulin to All Americans

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Health M&A: Financial Distress Driving Q3 Healthcare Deals

Health M&A: Financial Distress Driving Q3 Healthcare Deals

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |